Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mega Genomics Limited ( (HK:6667) ) has issued an update.
Mega Genomics Limited has proposed a final ordinary cash dividend of RMB 0.15 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 26 June 2026. Key payment details, including the Hong Kong dollar equivalent, exchange rate, ex-dividend date, record date, and payment date, will be announced later, leaving investors awaiting further clarity on the precise timetable and local-currency payout.
The dividend will be administered through Tricor Investor Services Limited as share registrar in Hong Kong, reinforcing the company’s use of established market infrastructure for corporate actions. While the announcement confirms a reward to shareholders from 2025 earnings, the absence of finalized dates and HKD terms means investors must monitor subsequent disclosures to fully assess timing and cash flow implications.
More about Mega Genomics Limited
Mega Genomics Limited is a Hong Kong-listed company operating in the genomics and life sciences sector, with its shares traded under stock code 06667. The company serves investors in the Hong Kong capital market and reports its financial performance on a calendar-year basis, providing returns to shareholders through ordinary cash dividends when conditions permit.
Average Trading Volume: 8,733
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.63B
See more data about 6667 stock on TipRanks’ Stock Analysis page.